| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Valve Prosthesis Implantation | 4 | 2019 | 563 | 1.690 |
Why?
|
| Heart Septal Defects, Atrial | 4 | 2020 | 125 | 1.510 |
Why?
|
| Heart Defects, Congenital | 14 | 2022 | 1697 | 1.240 |
Why?
|
| Pulmonary Valve | 2 | 2019 | 87 | 1.180 |
Why?
|
| Angioplasty, Balloon | 3 | 2017 | 183 | 1.160 |
Why?
|
| Heart Valve Prosthesis | 3 | 2023 | 386 | 1.110 |
Why?
|
| Cardiac Catheterization | 8 | 2023 | 687 | 1.000 |
Why?
|
| Mustard Plant | 1 | 2022 | 4 | 0.890 |
Why?
|
| Vacuum Curettage | 1 | 2022 | 5 | 0.890 |
Why?
|
| Stents | 6 | 2020 | 1096 | 0.830 |
Why?
|
| Pulmonary Artery | 4 | 2023 | 499 | 0.800 |
Why?
|
| Septal Occluder Device | 2 | 2019 | 49 | 0.770 |
Why?
|
| Heart-Assist Devices | 4 | 2022 | 1171 | 0.740 |
Why?
|
| Stenosis, Pulmonary Artery | 1 | 2019 | 5 | 0.690 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 52 | 0.690 |
Why?
|
| Aortic Coarctation | 2 | 2017 | 103 | 0.690 |
Why?
|
| Aortic Valve | 3 | 2019 | 581 | 0.690 |
Why?
|
| Foramen Ovale, Patent | 1 | 2019 | 22 | 0.670 |
Why?
|
| Superior Vena Cava Syndrome | 2 | 2016 | 36 | 0.650 |
Why?
|
| Transcatheter Aortic Valve Replacement | 2 | 2019 | 314 | 0.640 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 295 | 0.620 |
Why?
|
| Transposition of Great Vessels | 2 | 2017 | 124 | 0.610 |
Why?
|
| Hypoxia | 1 | 2020 | 443 | 0.610 |
Why?
|
| Aortic Diseases | 1 | 2020 | 206 | 0.610 |
Why?
|
| Treatment Outcome | 21 | 2022 | 32848 | 0.600 |
Why?
|
| Dyspnea | 1 | 2020 | 416 | 0.600 |
Why?
|
| Hypertension, Pulmonary | 4 | 2017 | 462 | 0.580 |
Why?
|
| Norwood Procedures | 1 | 2017 | 84 | 0.570 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2017 | 1237 | 0.560 |
Why?
|
| Heart Diseases | 2 | 2013 | 732 | 0.560 |
Why?
|
| Shock, Cardiogenic | 1 | 2018 | 228 | 0.540 |
Why?
|
| Bioprosthesis | 1 | 2017 | 167 | 0.530 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2014 | 69 | 0.530 |
Why?
|
| Arterial Switch Operation | 1 | 2015 | 19 | 0.520 |
Why?
|
| Heart Failure | 5 | 2022 | 2516 | 0.520 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2017 | 137 | 0.510 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2015 | 31 | 0.510 |
Why?
|
| Cardiology Service, Hospital | 1 | 2014 | 16 | 0.490 |
Why?
|
| Behcet Syndrome | 1 | 2014 | 17 | 0.490 |
Why?
|
| Aortic Valve Stenosis | 1 | 2019 | 476 | 0.480 |
Why?
|
| Hospitals, Pediatric | 3 | 2018 | 773 | 0.470 |
Why?
|
| Coronary Aneurysm | 1 | 2014 | 36 | 0.470 |
Why?
|
| Hemodynamics | 4 | 2020 | 935 | 0.460 |
Why?
|
| Health Resources | 1 | 2014 | 168 | 0.430 |
Why?
|
| Aneurysm, False | 1 | 2014 | 153 | 0.430 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2011 | 99 | 0.360 |
Why?
|
| Women's Health | 1 | 2011 | 205 | 0.340 |
Why?
|
| Prosthesis Design | 4 | 2019 | 749 | 0.330 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2020 | 303 | 0.300 |
Why?
|
| Humans | 39 | 2023 | 261506 | 0.280 |
Why?
|
| Fontan Procedure | 3 | 2019 | 155 | 0.270 |
Why?
|
| Adult | 21 | 2022 | 77950 | 0.260 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2023 | 67 | 0.220 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2018 | 581 | 0.200 |
Why?
|
| Ventricular Function, Left | 2 | 2017 | 603 | 0.200 |
Why?
|
| Female | 23 | 2022 | 141928 | 0.200 |
Why?
|
| Child | 8 | 2022 | 29154 | 0.190 |
Why?
|
| Hospital Mortality | 4 | 2017 | 1274 | 0.190 |
Why?
|
| Hope | 1 | 2020 | 13 | 0.180 |
Why?
|
| Familial Primary Pulmonary Hypertension | 2 | 2017 | 21 | 0.180 |
Why?
|
| Solutions | 1 | 2019 | 104 | 0.170 |
Why?
|
| Retrospective Studies | 12 | 2022 | 37905 | 0.170 |
Why?
|
| Off-Label Use | 1 | 2019 | 46 | 0.170 |
Why?
|
| Adolescent | 12 | 2019 | 31252 | 0.170 |
Why?
|
| Young Adult | 10 | 2018 | 21445 | 0.170 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2019 | 127 | 0.160 |
Why?
|
| Anticoagulants | 3 | 2022 | 787 | 0.160 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 248 | 0.160 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2018 | 163 | 0.150 |
Why?
|
| Syndrome | 1 | 2020 | 1351 | 0.150 |
Why?
|
| Thromboembolism | 1 | 2018 | 155 | 0.150 |
Why?
|
| Ductus Arteriosus | 1 | 2017 | 40 | 0.140 |
Why?
|
| Catheterization, Peripheral | 1 | 2018 | 158 | 0.140 |
Why?
|
| Vascular Access Devices | 1 | 2016 | 51 | 0.140 |
Why?
|
| Vena Cava, Superior | 1 | 2016 | 78 | 0.140 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 257 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2016 | 64 | 0.140 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2019 | 318 | 0.130 |
Why?
|
| Heart Transplantation | 1 | 2022 | 908 | 0.130 |
Why?
|
| Femoral Artery | 1 | 2016 | 210 | 0.130 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 429 | 0.130 |
Why?
|
| Executive Function | 1 | 2016 | 160 | 0.130 |
Why?
|
| Heart Arrest | 1 | 2019 | 358 | 0.130 |
Why?
|
| Heterografts | 1 | 2017 | 733 | 0.130 |
Why?
|
| Pulmonary Circulation | 1 | 2015 | 131 | 0.120 |
Why?
|
| Atrial Fibrillation | 1 | 2022 | 719 | 0.120 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 263 | 0.120 |
Why?
|
| Fluoroscopy | 1 | 2015 | 232 | 0.120 |
Why?
|
| Pacemaker, Artificial | 1 | 2016 | 213 | 0.120 |
Why?
|
| Thoracotomy | 1 | 2015 | 220 | 0.120 |
Why?
|
| Electric Countershock | 1 | 2014 | 71 | 0.120 |
Why?
|
| Aorta | 1 | 2017 | 692 | 0.120 |
Why?
|
| Male | 16 | 2019 | 123000 | 0.110 |
Why?
|
| Pulmonary Veins | 1 | 2015 | 174 | 0.110 |
Why?
|
| Stroke | 1 | 2022 | 1144 | 0.110 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 435 | 0.110 |
Why?
|
| Swine | 1 | 2017 | 1541 | 0.110 |
Why?
|
| Peripheral Arterial Disease | 1 | 2016 | 267 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2014 | 192 | 0.110 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2014 | 473 | 0.110 |
Why?
|
| Coronary Vessels | 1 | 2017 | 665 | 0.110 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2017 | 342 | 0.110 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 403 | 0.100 |
Why?
|
| Echocardiography | 1 | 2018 | 1182 | 0.100 |
Why?
|
| Thrombosis | 1 | 2018 | 781 | 0.100 |
Why?
|
| Postoperative Complications | 2 | 2017 | 5542 | 0.100 |
Why?
|
| Ultrasonography | 2 | 2015 | 1863 | 0.100 |
Why?
|
| Infant | 4 | 2019 | 13310 | 0.100 |
Why?
|
| Risk Factors | 6 | 2018 | 17523 | 0.100 |
Why?
|
| Survivors | 1 | 2016 | 1031 | 0.090 |
Why?
|
| Time Factors | 5 | 2017 | 12926 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 2 | 2022 | 543 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2015 | 6869 | 0.090 |
Why?
|
| Cognition | 1 | 2016 | 968 | 0.090 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2011 | 133 | 0.090 |
Why?
|
| Ambulatory Care | 1 | 2014 | 554 | 0.090 |
Why?
|
| Patient Admission | 1 | 2011 | 220 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 526 | 0.090 |
Why?
|
| Middle Aged | 9 | 2023 | 86204 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 4892 | 0.080 |
Why?
|
| Referral and Consultation | 1 | 2014 | 899 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 610 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 4320 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 2265 | 0.080 |
Why?
|
| Disease Management | 1 | 2013 | 1052 | 0.080 |
Why?
|
| Age Factors | 2 | 2014 | 5377 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2014 | 1148 | 0.070 |
Why?
|
| Administration, Oral | 2 | 2022 | 1544 | 0.070 |
Why?
|
| United States | 5 | 2018 | 15433 | 0.070 |
Why?
|
| Texas | 2 | 2014 | 6311 | 0.070 |
Why?
|
| Incidence | 2 | 2018 | 5673 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 1085 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1362 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 14889 | 0.060 |
Why?
|
| Survival Rate | 2 | 2018 | 12221 | 0.060 |
Why?
|
| Infant, Newborn | 4 | 2019 | 8223 | 0.060 |
Why?
|
| Hospitalization | 1 | 2012 | 2083 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 8865 | 0.060 |
Why?
|
| Tricuspid Valve | 1 | 2023 | 68 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 5539 | 0.050 |
Why?
|
| Pregnancy | 2 | 2014 | 7573 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2019 | 16273 | 0.050 |
Why?
|
| Warfarin | 1 | 2022 | 152 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 2403 | 0.050 |
Why?
|
| Prevalence | 3 | 2012 | 3260 | 0.040 |
Why?
|
| Disease Progression | 1 | 2011 | 6682 | 0.040 |
Why?
|
| Inheritance Patterns | 1 | 2017 | 139 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 712 | 0.040 |
Why?
|
| Phlebography | 1 | 2016 | 76 | 0.040 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2017 | 126 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 318 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 324 | 0.030 |
Why?
|
| Reaction Time | 1 | 2016 | 234 | 0.030 |
Why?
|
| Comorbidity | 2 | 2012 | 2352 | 0.030 |
Why?
|
| Europe | 1 | 2017 | 649 | 0.030 |
Why?
|
| Length of Stay | 2 | 2012 | 1900 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2016 | 233 | 0.030 |
Why?
|
| Attention | 1 | 2016 | 281 | 0.030 |
Why?
|
| Radiography, Interventional | 1 | 2016 | 305 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 4298 | 0.030 |
Why?
|
| Aged | 3 | 2014 | 70117 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 2422 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 703 | 0.030 |
Why?
|
| Prognosis | 1 | 2011 | 21713 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 1471 | 0.030 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2014 | 226 | 0.030 |
Why?
|
| Animals | 1 | 2017 | 59536 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 1178 | 0.030 |
Why?
|
| Endothelin Receptor Antagonists | 1 | 2011 | 22 | 0.030 |
Why?
|
| Phenylpropionates | 1 | 2011 | 19 | 0.030 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2011 | 25 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 2170 | 0.030 |
Why?
|
| Epoprostenol | 1 | 2011 | 75 | 0.020 |
Why?
|
| Heart Atria | 1 | 2014 | 352 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2016 | 846 | 0.020 |
Why?
|
| Reoperation | 1 | 2015 | 1382 | 0.020 |
Why?
|
| Transition to Adult Care | 1 | 2011 | 97 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 1085 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 655 | 0.020 |
Why?
|
| Pyridazines | 1 | 2011 | 293 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 395 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2011 | 226 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2014 | 1145 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 4109 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 2316 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 4314 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 6100 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 4549 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2016 | 9244 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2011 | 1823 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 1054 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 3890 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 12873 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 7702 | 0.010 |
Why?
|